Clinical and Molecular Hepatology (Clin Mol Hepatol), is an international, peer-reviewed, open- access journal published quarterly in English. Clin Mol Hepatol aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, Clin Mol Hepatol gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.

Clin Mol Hepatol publishes original papers, meta-analysis, letter to editor, case reports, reviews, guidelines, editorials, and liver image and pathology on all aspects of the field of hepatology.

《临床与分子肝病学》是一本国际性、同行评议、开放获取的英文季刊。《临床与分子肝病学》旨在分享肝胆疾病方面的先进和最新知识、趋势和理解，为临床医生、转化研究人员和基础科学家之间的积极辩论和讨论提供一个广阔的开放的学术论坛，并通过多学科方法改善公共卫生，特别是在资源有限的乙型病毒感染和肝细胞癌高发的亚太地区。此外，《临床与分子肝病学》优先考虑东亚、北亚、东南亚、中亚、南亚、西南亚、太平洋、非洲、中欧、东欧、中美洲和南美洲的肝胆疾病流行病学研究。《

临床与分子肝病学》发表有关肝病学领域各个方面的原创论文、荟萃分析、致编辑的信、病例报告、评论、指南、社论以及肝脏图像和病理学。